Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Janssen single dose Covid-19 vaccine authorised by UK medicines regulator
Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator. The […]
Vaccine Status Drives Over One Million New Users to the NHS App
Over 1.3 million new people have registered to use the NHS App since the addition […]
World-first Covid-19 Vaccine Booster Study Launches in UK
Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching […]
New Measures to Boost Response to B1.617.2 Variant
The B1.617.2 variant of concern is beginning to spread increasingly rapidly in certain areas across […]
UK Medicines Regulator Issues its First Authorisation Under Project Orbis
A post-surgery treatment for lung cancer will be the first to receive an authorisation from […]
Transforming the UK into a Life Sciences Superpower
Patients are set to benefit from better research, treatment, care and improved clinical decision-making, as […]
Hancock: Modern Medicine May Cease to Exist Without Global AMR Action
Health and Social Care Secretary, Matt Hancock, will today call for urgent global action in […]
Government Launches Covid-19 Antivirals Taskforce to Roll out Innovative Home Treatments This Autumn
A new Antivirals Taskforce has been launched by the government to identify treatments for UK […]
Festival Republic Joins Government Pilot Programme with a Live Event to Trial the Safe Return of Fans
The Sefton Park Pilot, in partnership with Culture Liverpool, will further trial approaches to managing […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more